Bio-Techne Corporation

Healthcare · Biotechnology · United States

Last price 72.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 11.40B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, a...